ARCHIVES

GSK’s Pazopanib Benefits Similar to Sunitinib; Sponsor Points to More Favorable Safety Profile

This article is from The Cancer Letter archive.

Vol. 36 No. 8 | August 30, 2013

Download PDF Visit The Full Archive

Related Articles

Zaltrap Economics 101: The Pricing And Repricing of an Expensive Drug

November 16, 2012

In Brief: NIH Conference To Explore Conflict Of Interest Issues; Five NCUI Executive Win PHS Awards

May 26, 1989

Kimes, Lenfant, To Retire

July 11, 2003

In Brief: Construction Grant Applications Due Oct. 1 For Funding In FY 1982; Backlog Cleared Out

June 19, 1981

In Brief: Dewys Asked To Step Down As Prevention Head By Greenwald; Paul Sherlock Of MSK Dies At 56

May 17, 1985

Edelson To Step Down As Yale Center Director.

January 11, 2008